TickerFacts.

Nephros Inc (NEPH): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$7.16M
Year ended 2025-12-31
$8.03M
Trailing 12 months to 2026-06-30
+11.0%
3-year compound annual growth
2010-12-31: $1.82M2011-12-31: $1.35M2012-12-31: $737.0K2013-12-31: $898.0K2014-12-31: $549.0K2015-12-31: $884.0K2016-12-31: $1.03M2017-12-31: $1.52M2018-12-31: $2.48M2019-12-31: $4.25M2020-12-31: $3.65M2021-12-31: $4.58M2022-12-31: $5.24M2023-12-31: $5.83M2024-12-31: $5.44M2025-12-31: $7.16M$7.16M
2010-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$7.16M+31.7%2026-03-12, From 2025-01-01
2024-12-31$5.44M-6.8%2026-03-12, From 2024-01-01
2023-12-31$5.83M+11.2%2025-03-24, From 2023-01-01
2022-12-31$5.24M+14.4%2024-03-15, From 2022-01-01
2021-12-31$4.58Mn/c2023-03-23, From 2021-01-01
2020-12-31$3.65M-14.2%2022-03-03, From 2020-01-01
2019-12-31$4.25M+71.1%2021-03-01, From 2019-01-01
2018-12-31$2.48M+63.7%2020-02-27, From 2018-01-01
2017-12-31$1.52M+47.9%2019-03-12, From 2017-01-01
2016-12-31$1.03M+16.1%2018-02-26, From 2016-01-01
2015-12-31$884.0K+61.0%2017-03-20, From 2015-01-01
2014-12-31$549.0K-38.9%2016-03-30, From 2014-01-01
2013-12-31$898.0K+21.8%2015-04-15, From 2013-01-01
2012-12-31$737.0K-45.2%2014-03-28, From 2012-01-01
2011-12-31$1.35M-25.9%2013-03-04, From 2011-01-01
2010-12-31$1.82Mn/a2012-03-22, From 2010-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Nephros Inc (NEPH)2025-12-31$7.16M+31.7%
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$12.11M+37.3%
Spectral AI, Inc. (MDAI)2025-12-31$10.72M-34.2%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$6.90M+14.8%
Profound Medical Corp. (PROF)2025-12-31$4.71M+29.2%
Biotricity Inc. (BTCY)2026-03-31$3.05M-5.5%
DarioHealth Corp. (DRIO)2025-12-31$9.69M-29.6%
Baird Medical Investment Holdings Ltd (BDMD)2025-12-31$3.65M-16.7%
Allurion Technologies, Inc. (ALUR)2025-12-31$5.66M-46.6%

Compare NEPH, SNOA, MDAI, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗